Cargando…
Is increasing the dose of Entecavir effective in partial virological responders?
OBJECTIVE: To analyze the effect of increasing Entecavir (ETV) dosage in patients with chronic hepatitis B (CHB) who partially responded to ETV after 1 year. METHODS: Twenty-three hepatitis B e antigen (HBeAg)-positive and 36 HBeAg-negative patients with CHB were treated with ETV 0.5 mg daily. After...
Autores principales: | Erturk, Ayse, Adnan Akdogan, Remzi, Parlak, Emine, Cure, Erkan, Cumhur Cure, Medine, Ozturk, Cinar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047834/ https://www.ncbi.nlm.nih.gov/pubmed/24936126 http://dx.doi.org/10.2147/DDDT.S61045 |
Ejemplares similares
-
Clinical Significance of Neutrophil Gelatinase-Associated Lipocalin in Crimean-Congo Hemorrhagic Fever
por: Erturk, Ayse, et al.
Publicado: (2015) -
NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection
por: Cumhur Cure, Medine, et al.
Publicado: (2020) -
Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection
por: Cure, Erkan, et al.
Publicado: (2020) -
COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets
por: Cure, Erkan, et al.
Publicado: (2020) -
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic
por: Cure, Erkan, et al.
Publicado: (2020)